Trial Profile

A Phase II, Open-Label Trial, to Evaluate the Safety, Tolerability and Antiviral Activity of TMC125 in Antiretroviral Experienced HIV-1 Infected Children and Adolescents.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 05 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etravirine (Primary) ; Darunavir
Indications HIV-1 infections
Focus Adverse reactions
Acronyms PIANO
Sponsors Janssen R&D Ireland

Most Recent Events

13 Nov 2015 Final results published in the Antiviral Therapy.
30 Jun 2012 Additional trial location added as reported by European Clinical Trials Database.
14 Mar 2012 Actual number of patients changed from 101 to 103 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com